(Q48077401)

8 February 2018

title

6-Hydroxydopamine as a tool to understand adaptive immune system-induced dopamine neurodegeneration in Parkinson's disease. (English)

1 reference

8 February 2018

1 reference

1 reference

Shaji Theodore

1

1 reference

8 February 2018

William Maragos

series ordinal

2

1 reference

8 February 2018

publication date

27 July 2015

1 reference

8 February 2018

Immunopharmacology and Immunotoxicology

published in

1 reference

8 February 2018

volume

37

1 reference

8 February 2018

issue

4

1 reference

8 February 2018

page(s)

393-399

1 reference

8 February 2018

Neurodegeneration and neuroprotection in Parkinson disease

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2015.1070172

Glial reactions in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2015.1070172

Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2015.1070172

Fcγ receptors are required for NF-κB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2015.1070172

A possible role for humoral immunity in the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2015.1070172

Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2015.1070172

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2015.1070172

Toxin-induced models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2015.1070172

The 6-hydroxydopamine model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2015.1070172

Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2015.1070172

Inflammation and adaptive immunity in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2015.1070172

Activated immune cells in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2015.1070172

Role of Fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2015.1070172

Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2015.1070172

NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2015.1070172

NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2015.1070172

10.3109/08923973.2015.1070172

21 January 2018

Identifiers

DOI

1 reference

8 February 2018

PubMed ID

26211726

1 reference

8 February 2018